- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder
Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.
Featuring
-
Larry Reccoppa, MD
Regional Psychiatric Director, Wellpath; Staff Psychiatrist, Behavioral Health Services CMHC
-
Jacquelyn Canning, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison
-
Aneta Fornal, PharmD (OPDC)
Clinical & Scientific Director
Speaker Larry Reccoppa, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Speakers Jacquelyn Canning, PharmD, BCPP and Aneta Fornal, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
June 3 12:00 pm to 1:00 pm
Register
This event registration is closed.
Stay Connected:
- Resource Library